DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 158 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,533 | +14.3% | 103,870 | +0.1% | 0.08% | +23.9% |
Q2 2023 | $1,341 | -23.4% | 103,776 | -41.8% | 0.07% | -14.1% |
Q1 2023 | $1,750 | -7.9% | 178,437 | -0.1% | 0.08% | -15.2% |
Q4 2022 | $1,900 | -99.9% | 178,530 | -0.6% | 0.09% | +2.2% |
Q3 2022 | $1,876,000 | +42.2% | 179,602 | +71.3% | 0.09% | +55.2% |
Q2 2022 | $1,319,000 | +16.1% | 104,841 | 0.0% | 0.06% | +28.9% |
Q1 2022 | $1,136,000 | -21.3% | 104,841 | +2.3% | 0.04% | +2.3% |
Q4 2021 | $1,443,000 | -7.0% | 102,497 | +26.9% | 0.04% | -12.0% |
Q3 2021 | $1,552,000 | +94.0% | 80,800 | -0.5% | 0.05% | +85.2% |
Q2 2021 | $800,000 | +0.3% | 81,200 | 0.0% | 0.03% | -3.6% |
Q1 2021 | $798,000 | +133.3% | 81,200 | +5.6% | 0.03% | +133.3% |
Q4 2020 | $342,000 | +24.8% | 76,900 | +20.9% | 0.01% | +33.3% |
Q3 2020 | $274,000 | – | 63,600 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |